Univest
Univest
  • Markets
  • 3 US Generics Exporter, Anti-Infectives Franchise Owner and Biggest Indian Drug Maker by Value Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma

    • October 29, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 US Generics Exporter, Anti-Infectives Franchise Owner and Biggest Indian Drug Maker by Value Stocks With a Strong Future Roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma

    Generics, Anti-infective and Pharma Leader with a strong future roadmap: Alembic Pharmaceuticals, Alkem Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Research Led Pharma Company, Chronic and Acute Therapy Leader and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Mankind Pharma and Sun Pharma

    • October 29, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Research Led Pharma Company, Chronic and Acute Therapy Leader and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Glenmark Pharmaceuticals, Mankind Pharma and Sun Pharma

    Research, Chronic Brand and Leader Pharma with a strong future roadmap: Glenmark Pharmaceuticals, Mankind Pharma and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Chronic Therapy Brand Company, Formulations Exporter and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma

    • October 28, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Chronic Therapy Brand Company, Formulations Exporter and Largest Indian Pharma Group Stocks With a Strong Future Roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma

    Chronic Brand, Export and Leader Pharma with a strong future roadmap: Eris Lifesciences, Marksans Pharma and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Active Ingredients Maker, Contract Formulations Company and Branded Generics Leader Stocks With a Strong Future Roadmap: Divi’s Laboratories, Innova Captab and Sun Pharma

    • October 28, 2026
    • Posted by: Neeraj Pandey
    • Category: Best Stocks
    No Comments
    3 Active Ingredients Maker, Contract Formulations Company and Branded Generics Leader Stocks With a Strong Future Roadmap: Divi's Laboratories, Innova Captab and Sun Pharma

    Pharma Ingredient, Contract and Generics Stocks with a strong future roadmap: Divi’s Laboratories, Innova Captab and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Chronic Care Brands Company, Cardiac and Central Nervous System Therapy Leader and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals and Sun Pharma

    • October 28, 2026
    • Posted by: Chaitanya Auti
    • Category: Best Stocks
    No Comments
    3 Chronic Care Brands Company, Cardiac and Central Nervous System Therapy Leader and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals and Sun Pharma

    Prescription Brand Leader Pharma Stocks with a strong future roadmap: JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • 3 Branded Generics Exporter, Latin America Focused Drug Maker and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma

    • October 28, 2026
    • Posted by: Kunal Singla
    • Category: Best Stocks
    No Comments
    3 Branded Generics Exporter, Latin America Focused Drug Maker and Largest Indian Pharmaceutical Company Stocks With a Strong Future Roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma

    Africa, Latin America and Specialty Drug Stocks with a strong future roadmap: Ajanta Pharma, Caplin Point Laboratories and Sun Pharma. Compare price, valuation, return on equity and revenue growth as of 27 October 2026.

    read more
  • Stocks to Watch Today, 8 October: TCS Results, Tata Steel Q2 Update, Sun Pharma’s Rs 15,000 Crore Debt Plan, Ola Electric Rights Issue, Vedanta Dividend and the GST Council Meeting After a Weak Close

    • October 8, 2026
    • Posted by: Chaitanya Auti
    • Category: News
    No Comments
    Stocks to Watch Today, 8 October: TCS Results, Tata Steel Q2 Update, Sun Pharma's Rs 15,000 Crore Debt Plan, Ola Electric Rights Issue, Vedanta Dividend and the GST Council Meeting After a Weak Close

    Stocks to watch today, 8 October: TCS results, Tata Steel update, Sun Pharma debt plan, Ola Electric rights and Vedanta dividend.

    read more
  • Sun Pharma results Q2FY23

    • November 4, 2022
    • Posted by: Sheen Hitaishi
    • Category: Market
    No Comments
    read more
  • 1
  • 2
  • 3